{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T03:29:28Z","timestamp":1790220568809,"version":"4.1.0"},"reference-count":32,"publisher":"Wiley","issue":"2","license":[{"start":{"date-parts":[[2009,10,13]],"date-time":"2009-10-13T00:00:00Z","timestamp":1255392000000},"content-version":"vor","delay-in-days":4334,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["European Journal of Biochemistry"],"published-print":{"date-parts":[[1997,12]]},"abstract":"<jats:p>1\u2010<jats:italic>O<\/jats:italic>\u2010Alkylglycerols (alkyl\u2010Gro), naturally occurring compounds abundant in shark liver oil, protect patients from radiotherapy side\u2010effects. However, the protection mechanism is not well understood. It might be mediated by alkyl\u2010Gro incorporation into pools of platelet\u2010activating factor (PAF) precursor and subsequent modification of PAF biosynthesis. Using a <jats:sup>3<\/jats:sup>H\u2010labelled or unlabelled natural alkyl\u2010Gro mixture, in which prominent alkyl chains were C18:1(9) (54\u201365%), C16:1(7) (5\u201315.5%), and C16:0 (5\u201310%), we investigated the incorporation of alkyl\u2010Gro into phospholipids of human leukemic monocyte\u2010like THP\u20101 cells. Incubation of cells for 24 h with [<jats:sup>3<\/jats:sup>H]alkyl\u2010Gro (10 \u03bcM) resulted in their incorporation into 1\u2010<jats:italic>O<\/jats:italic>\u2010alkyl\u20102\u2010acyl\u2010<jats:italic>sn<\/jats:italic>\u2010glycero\u20103\u2010phosphocholine (1097 \u00b1 25.1 pmol\/2\u00d710<jats:sup>6<\/jats:sup> cells) and into 1\u2010alkyl\u20102\u2010acyl\u2010<jats:italic>sn<\/jats:italic>\u2010glycero\u20103\u2010phosphoethanolamine (640.4 + 12.5 pmol\/2\u00d710<jats:sup>6<\/jats:sup> cells) with a total yield of 6.5%. Such incorporation induced production of 1\u2010<jats:italic>O<\/jats:italic>\u2010[<jats:sup>3<\/jats:sup>H]alkyl\u20102\u2010acetyl\u2010<jats:italic>sn<\/jats:italic>\u2010glycero\u20103\u2010phosphocholine ([<jats:sup>3<\/jats:sup>H]PAF), which was increased after stimulation by the calcium ionophore A23187. HPLC analysis of the [<jats:sup>3<\/jats:sup>H]PAF molecular species indicated that the three major [<jats:sup>3<\/jats:sup>H]alkyl\u2010Gro were used for [<jats:sup>3<\/jats:sup>H]PAF synthesis in ratios similar to that of the mixture. Total production of biologically active PAF, as measured by the platelet\u2010aggregation bioassay, was also increased by alkyl\u2010Gro incorporation in resting (+20%) and in A23187\u2010stimulated (+59%) THP\u20101 cells. HPLC analysis of the [<jats:sup>3<\/jats:sup>H]PAF produced in the presence of [<jats:sup>3<\/jats:sup>H]acetate, confirmed that levels of PAF, but not of its 1\u2010acyl analog, were increased by alkyl\u2010Gro incorporation in resting and stimulated cells. However, the rise in [<jats:sup>3<\/jats:sup>H]acetyl\u2010PAF, which resulted mainly from C16:0 PAF, was reduced by about 50% in the presence of the PAF\u2010receptor antagonist SR 27417, providing evidence that stimulation of total PAF synthesis was caused by the increase in the precursor pool and autocrine amplification of PAF\u2010induced PAF production. Thus, the supplementation of THP\u20101 cells in culture with naturally occurring alkyl\u2010Gro led to the incorporation of alkyl\u2010Gro into ether\u2010containing phospholipids, which were subsequently used for PAF synthesis. Furthermore, alkyl\u2010Gro incorporation resulted in a significant rise in PAF production by THP\u20101 cells under resting and stimulated conditions. These results may be of importance for modulating PAF production in several pathophysiological conditions, such as peroxysome deficiencies, that are associated with a lack of ether lipid synthesis.<\/jats:p>","DOI":"10.1111\/j.1432-1033.1997.0242a.x","type":"journal-article","created":{"date-parts":[[2004,9,2]],"date-time":"2004-09-02T18:31:04Z","timestamp":1094149864000},"page":"242-248","source":"Crossref","is-referenced-by-count":26,"title":["Modulation of Platelet\u2010Activating\u2010Factor Production by Incorporation of Naturally Occurring 1\u2010<i>O<\/i>\u2010Alkylglycerols in Phospholipids of Human Leukemic Monocyte\u2010Like THP\u20101 Cells"],"prefix":"10.1111","volume":"250","author":[{"given":"Aziz","family":"Hichami","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Val\u00e9rie","family":"Duroudier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V\u00e9ronique","family":"Leblais","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurent","family":"Vernhet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fran\u00e7ois","family":"Le Goffic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ewa","family":"Ninio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alain","family":"Legrand","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2009,10,13]]},"reference":[{"key":"e_1_2_3_2_2","doi-asserted-by":"publisher","DOI":"10.3891\/acta.chem.scand.24-0730"},{"key":"e_1_2_3_3_2","first-page":"1","article-title":"Alkoxyglycerols and their use in radiation treatment","volume":"223","author":"Brohult A.","year":"1963","journal-title":"Acta Radiol Suppl."},{"key":"e_1_2_3_4_2","doi-asserted-by":"publisher","DOI":"10.3109\/00016348609161500"},{"key":"e_1_2_3_5_2","doi-asserted-by":"publisher","DOI":"10.3109\/00016347809154203"},{"key":"e_1_2_3_6_2","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.2910530123"},{"key":"e_1_2_3_7_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF02544013"},{"key":"e_1_2_3_8_2","doi-asserted-by":"publisher","DOI":"10.1159\/000176161"},{"key":"e_1_2_3_9_2","doi-asserted-by":"publisher","DOI":"10.2165\/00003495-199142010-00002"},{"key":"e_1_2_3_10_2","doi-asserted-by":"publisher","DOI":"10.2165\/00003495-199142020-00002"},{"key":"e_1_2_3_11_2","doi-asserted-by":"crossref","first-page":"660","DOI":"10.4049\/jimmunol.147.2.660","article-title":"Differential synthesis of 1\u2010acyl\u20102\u2010acetyl\u2010sn\u2010glycero\u20103\u2010phospho\u2010choline and platelet\u2010activating factor by human inflammatory cells","volume":"147","author":"Triggiani M.","year":"1991","journal-title":"J. Immunol."},{"key":"e_1_2_3_12_2","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.2910260208"},{"key":"e_1_2_3_13_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1432-1033.1996.00048.x"},{"key":"e_1_2_3_14_2","doi-asserted-by":"publisher","DOI":"10.1139\/y59-099"},{"key":"e_1_2_3_15_2","doi-asserted-by":"publisher","DOI":"10.1016\/0076-6879(90)87016-V"},{"key":"e_1_2_3_16_2","doi-asserted-by":"publisher","DOI":"10.1038\/269170a0"},{"key":"e_1_2_3_17_2","doi-asserted-by":"publisher","DOI":"10.1002\/jlb.54.4.296"},{"key":"e_1_2_3_18_2","first-page":"241","volume-title":"Biochemistry of lipids, lipoproteins and membranes","author":"Snyder F.","year":"1991"},{"key":"e_1_2_3_19_2","doi-asserted-by":"publisher","DOI":"10.1016\/0005-2760(93)90112-M"},{"key":"e_1_2_3_20_2","first-page":"97","article-title":"Perspectives in platelet\u2010activating factor research","volume":"59","author":"Braquet P.","year":"1987","journal-title":"Pharmacol. Rev."},{"key":"e_1_2_3_21_2","doi-asserted-by":"crossref","first-page":"9140","DOI":"10.1016\/S0021-9258(19)38822-2","article-title":"Distinct platelet\u2010activating factor binding sites in synaptic endings and in intracellular membranes of rat cerebral cortex","volume":"265","author":"Marcheselli V. L.","year":"1990","journal-title":"J. Biol. Chem."},{"key":"e_1_2_3_22_2","doi-asserted-by":"publisher","DOI":"10.1002\/jnr.490370108"},{"key":"e_1_2_3_23_2","doi-asserted-by":"publisher","DOI":"10.1002\/jnr.490240414"},{"key":"e_1_2_3_24_2","doi-asserted-by":"crossref","first-page":"892","DOI":"10.4049\/jimmunol.133.2.892","article-title":"Biosynthesis of PAF\u2010acether (platelet\u2010activating factor) VII. Precursors of PAF\u2010acether and acetyl\u2010transferase activity in human leucocytes","volume":"133","author":"Jouvin\u2010Marche E.","year":"1984","journal-title":"J. Immunol."},{"key":"e_1_2_3_25_2","doi-asserted-by":"publisher","DOI":"10.1042\/bj3050689"},{"key":"e_1_2_3_26_2","doi-asserted-by":"publisher","DOI":"10.3181\/00379727-190-42839"},{"key":"e_1_2_3_27_2","doi-asserted-by":"crossref","first-page":"1559","DOI":"10.4049\/jimmunol.138.5.1559","article-title":"Species\u2010specific variations in the molecular heterogeneity of the platelet\u2010activating factor","volume":"138","author":"Ramesha C. S.","year":"1987","journal-title":"J. Immunol"},{"key":"e_1_2_3_28_2","doi-asserted-by":"crossref","first-page":"14554","DOI":"10.1016\/S0021-9258(17)42636-6","article-title":"The molecular species distribution of platelet\u2010activating factor synthetized by rabit and human neutrophils","volume":"259","author":"Mueller H. W.","year":"1984","journal-title":"J. Biol. Chem."},{"key":"e_1_2_3_29_2","first-page":"639","article-title":"PAF molecular heterogeneity: pathobiological implications","volume":"69","author":"McManus L. M.","year":"1993","journal-title":"Lab. Invest."},{"key":"e_1_2_3_30_2","doi-asserted-by":"publisher","DOI":"10.1203\/00006450-199409000-00006"},{"key":"e_1_2_3_31_2","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1182\/blood.V70.2.460.460","article-title":"Age related deficiency of the synthesis of platelet activating factor by leukocytes from Zellweger patients","volume":"70","author":"Sturk A.","year":"1987","journal-title":"Blood"},{"key":"e_1_2_3_32_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-2275(20)34317-0"},{"key":"e_1_2_3_33_2","doi-asserted-by":"publisher","DOI":"10.1016\/0300-9084(93)90076-5"}],"container-title":["European Journal of Biochemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1432-1033.1997.0242a.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/febs.onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1432-1033.1997.0242a.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,31]],"date-time":"2023-10-31T10:18:33Z","timestamp":1698747513000},"score":1,"resource":{"primary":{"URL":"https:\/\/febs.onlinelibrary.wiley.com\/doi\/10.1111\/j.1432-1033.1997.0242a.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1997,12]]},"references-count":32,"journal-issue":{"issue":"2","published-print":{"date-parts":[[1997,12]]}},"alternative-id":["10.1111\/j.1432-1033.1997.0242a.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1432-1033.1997.0242a.x","archive":["Portico"],"relation":{},"ISSN":["0014-2956","1432-1033"],"issn-type":[{"value":"0014-2956","type":"print"},{"value":"1432-1033","type":"electronic"}],"subject":[],"published":{"date-parts":[[1997,12]]}}}